» Articles » PMID: 29445149

Let-7c Inhibits Cholangiocarcinoma Growth but Promotes Tumor Cell Invasion and Growth at Extrahepatic Sites

Overview
Journal Cell Death Dis
Date 2018 Feb 16
PMID 29445149
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cholangiocarcinoma (CCA) is a cancer type with high postoperative relapse rates and poor long-term survival largely due to tumor invasion, distant metastasis, and multidrug resistance. Deregulated microRNAs (miRNAs) are implicated in several cancer types including CCA. The specific roles of the miRNA let-7c in cholangiocarcinoma are not known and need to be further elucidated. In our translational study we show that microRNA let-7c expression was significantly downregulated in human cholangiocarcinoma tissues when compared to adjacent tissues of the same patient. Let-7c inhibited the tumorigenic properties of cholangiocarcinoma cells including their self-renewal capacity and sphere formation in vitro and subcutaneous cancer cell growth in vivo. Ectopic let-7c overexpression suppressed migration and invasion capacities of cholangiocarcinoma cell lines in vitro, however, promoted distant invasiveness in vivo. Furthermore, we found that let-7c regulated the aforementioned malignant biological properties, at least in part, through regulation of EZH2 protein expression and through the DVL3/β-catenin axis. The miRNA let-7c thus plays an important dual role in regulating tumorigenic and metastatic abilities of human cholangiocarcinoma through mechanisms involving EZH2 protein and the DVL3/β-catenin axis.

Citing Articles

MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies.

Fagoonee S, Weiskirchen R Cells. 2024; 13(23).

PMID: 39682684 PMC: 11640337. DOI: 10.3390/cells13231935.


Pan-cancer analysis of B3GNT5 with potential implications for cancer immunotherapy and cancer stem cell stemness.

Peng F, Feng Y, Yu S, He R, Wang H, Xie Y PLoS One. 2024; 19(12):e0314609.

PMID: 39671359 PMC: 11642946. DOI: 10.1371/journal.pone.0314609.


Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysis.

Zhou C, Wang W, Mu Y, Meng M Front Immunol. 2024; 15:1393404.

PMID: 39206183 PMC: 11349560. DOI: 10.3389/fimmu.2024.1393404.


Comprehensive analysis of miRNA-mRNA regulatory pairs associated with colorectal cancer and the role in tumor immunity.

Liu C, Yu C, Song G, Fan X, Peng S, Zhang S BMC Genomics. 2023; 24(1):724.

PMID: 38036953 PMC: 10688136. DOI: 10.1186/s12864-023-09635-4.


Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion.

Lucarini V, Nardozi D, Angiolini V, Benvenuto M, Focaccetti C, Carrano R Biomedicines. 2023; 11(6).

PMID: 37371856 PMC: 10296425. DOI: 10.3390/biomedicines11061761.


References
1.
Zhou W, Fong M, Min Y, Somlo G, Liu L, Palomares M . Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014; 25(4):501-15. PMC: 4016197. DOI: 10.1016/j.ccr.2014.03.007. View

2.
Timmer M, Beuers U, Fockens P, Ponsioen C, Rauws E, Wang K . Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma. Inflamm Bowel Dis. 2013; 19(8):1789-97. DOI: 10.1097/MIB.0b013e318281f49a. View

3.
Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A . The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol. 2010; 52(5):698-704. DOI: 10.1016/j.jhep.2009.12.024. View

4.
Chen L, Mai W, Chen M, Hu J, Zhuo Z, Lei X . Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Pharmacol Res. 2017; 123:130-142. DOI: 10.1016/j.phrs.2017.07.009. View

5.
Sun D, Layer R, Mueller A, Cichewicz M, Negishi M, Paschal B . Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Oncogene. 2013; 33(11):1448-57. PMC: 3915043. DOI: 10.1038/onc.2013.77. View